1.
Galicia clin
; 84(4): 33-34, Oct.-Nov.-Dec. 2023.
Artigo
em Espanhol
| IBECS
| ID: ibc-230221
RESUMO
We present the case of a patient with a history of multiple sclerosis under chronic fingolimod treatment who presents abdominal pain associated with jaundice associated with transaminitis that by biopsy is associated with late hepatotoxicity due to fingolimod. (AU)
Se presenta el caso de una paciente con antecedente de esclerosis múltiple en manejo con fingolimod de manera crónica quien presenta dolor abdominal asociado a ictericia asociado a transaminitis que por biopsia se asocia a hepatotoxicidad tardía debido a fingolimod. (AU)